MD3880818T2 - Acizi nucleici pentru inhibarea expresei LPA într-o celulă - Google Patents

Acizi nucleici pentru inhibarea expresei LPA într-o celulă

Info

Publication number
MD3880818T2
MD3880818T2 MDE20210897T MDE20210897T MD3880818T2 MD 3880818 T2 MD3880818 T2 MD 3880818T2 MD E20210897 T MDE20210897 T MD E20210897T MD E20210897 T MDE20210897 T MD E20210897T MD 3880818 T2 MD3880818 T2 MD 3880818T2
Authority
MD
Moldova
Prior art keywords
lpa
cell
nucleic acids
inhibiting expression
expression
Prior art date
Application number
MDE20210897T
Other languages
English (en)
Inventor
David Anthony Rider
Lucas Bethge
Christian Frauendorf
Adrien Weingaertner
Judith Hauptmann
Sibylle Dames
Steffen Schubert
Stephan Tenbaum
Original Assignee
Silence Therapeutics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Silence Therapeutics Gmbh filed Critical Silence Therapeutics Gmbh
Priority claimed from PCT/EP2019/081158 external-priority patent/WO2020099476A1/en
Publication of MD3880818T2 publication Critical patent/MD3880818T2/ro

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Prezenta invenţie se referă la produse şi compoziţii şi la utilizările acestora. În special, invenţia se referă la produse de acid nucleic care interferează cu expresia genei LPA sau inhibă exprimarea acesteia, de preferinţă pentru utilizare ca tratament, prevenire sau reducere a riscului de a suferi de boli cardiovasculare cum ar fi boala coronariană sau stenoza aortică sau accidentul vascular cerebral sau orice altă tulburare, patologia sau sindromul legat de niveluri crescute de particule de Lp(a).
MDE20210897T 2018-11-13 2019-11-13 Acizi nucleici pentru inhibarea expresei LPA într-o celulă MD3880818T2 (ro)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP2018000811 2018-11-13
EP19174466 2019-05-14
PCT/EP2019/081158 WO2020099476A1 (en) 2018-11-13 2019-11-13 Nucleic acids for inhibiting expression of lpa in a cell

Publications (1)

Publication Number Publication Date
MD3880818T2 true MD3880818T2 (ro) 2023-01-31

Family

ID=85035533

Family Applications (1)

Application Number Title Priority Date Filing Date
MDE20210897T MD3880818T2 (ro) 2018-11-13 2019-11-13 Acizi nucleici pentru inhibarea expresei LPA într-o celulă

Country Status (1)

Country Link
MD (1) MD3880818T2 (ro)

Similar Documents

Publication Publication Date Title
ZA202003371B (en) Nucleic acids for inhibiting expression of lpa in a cell
PH12021550801A1 (en) Nucleic acids for inhibiting expression of lpa in a cell
Liy et al. Nitric oxide modulation in neuroinflammation and the role of mesenchymal stem cells
PH12020500622A1 (en) 17á-HYDROXYSTEROID DEHYDROGENASE TYPE 13 (HSD17B13) IRNA COMPOSITIONS AND METHODS OF USE THEREOF
MX2021005047A (es) Compuestos de 6-azabenzimidazol sustituidos como inhibidores de hpk1.
EP4219713A3 (en) Products and compositions
MA34909B1 (fr) Triterpénoïdes modifi2s en c-17 et c-3 presentant une activité inhibitrice de la maturation du vih
EA201391032A1 (ru) Новые гетероциклические производные и их применение в лечении неврологических расстройств
PH12017500977A1 (en) 1-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4h-pyrrolo[3,2-d]pyrimidin-4-ones as inhibitors of myeloperoxidase
WO2017022962A8 (ko) Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물
MX2015009512A (es) Dihidropirimidinonas biciclicas sustituidas y su uso como inhibidores de la actividad de elastasa neutrofilica.
EP4219714A3 (en) Rna interference mediated inhibition of tmprss6
WO2019014530A8 (en) LACTATE DEHYDROGENASE A (LDHA) RNAI COMPOSITIONS AND METHODS OF USE
MY182438A (en) Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrohil elastase activity
BR112019002204A2 (pt) reelin composições para tratamento de problemas neurológicos
MA43960A (fr) Triterpénoïdes modifiés en c-3 et c-17 utilisés comme inhibiteurs du vih-1
MD3880818T2 (ro) Acizi nucleici pentru inhibarea expresei LPA într-o celulă
MA39406B1 (fr) Promédicament de la 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-d-proline
WO2016032127A3 (ko) Tlr4에 lps와의 경쟁적 결합을 통한 항산화 및 항염증 활성을 갖는 신규 화합물 및 이의 의학적 용도
PH12020551060A1 (en) Methods of treating chronic inflammatory diseases
EA202092092A1 (ru) Фармацевтические композиции с высокими лекарственными нагрузками среднецепочечных триглицеридов и связанные с ними способы
WO2017081218A3 (en) Anti-human il-3 antibodies, their use in treatment of a disease or malfunction associated with elevated expression or levels of il-3, and their use in a method to detect human il-3
FI3503899T3 (fi) Tuote ja menetelmä uridiinipitoisuuden lisäämiseksi plasmassa
SG10201903656RA (en) Pharmaceutical composition comprising a beta blocker and an angiotensin converting enzyme inhibitor
TR201914037A2 (tr) Alantolacton etken maddesi̇ni̇n multi̇ple sklerozi̇s hastaliğinda i̇laç adayi olarak kullanilmasi